SSCT (revised) .pdf

File information


Original filename: SSCT (revised).pdf
Title: Microsoft Word - SSCT (revised).docx

This PDF 1.3 document has been generated by Word / Mac OS X 10.10.5 Quartz PDFContext, and has been sent on pdf-archive.com on 16/07/2016 at 14:08, from IP address 171.249.x.x. The current document download page has been viewed 252 times.
File size: 97 KB (1 page).
Privacy: public file


Download original PDF file


SSCT (revised).pdf (PDF, 97 KB)


Share on social networks



Link to this file download page



Document preview


 

Special Issue on

Safety of Stem Cell Transplantation
There has been a significant interest in clinical applications of stem cells in recent years,
and the safety these therapies is of particular interest to both scientists and physicians.
There is interest in the potential risk of tumorigenesis in vivo after stem cell
transplantation with several hypotheses suggesting that tumorigenesis and some side
effects may be related to stem cell characteristics and modifications in stem cells during
the in vitro long-term expansion. Some studies have shown that the use of stem cells
without in vitro expansion was safe in both preclinical and clinical applications.
Although there was some evidence of genetic alterations of expanded stem cells, in vitro
expanded stem cells have been used in Phase II and Phase III clinical trials for different
diseases. All trials showed that expanded stem cell transplantation was safe and had
beneficial results on disease improvement.
In this special issue, we invite researchers to submit original research and review articles to
contribute to the topic ‘SAFETY OF STEM CELL TRANSPLANTATION’. Potential topics
include, but are not limited to:
- Tumorigenesis or side effects and complications of stem cell transplantation
- Long-term safety of stem cell transplantation
- Safety of non-expanded stem cells therapy
- Safety of ex-vivo expanded stem cells therapy
- Safety of autologous stem cell transplantation
- Safety of allogenic stem cells for stem cell transplantation
- Preclinical safety assessment of stem cell transplantation
- Safety of in-vitro assessment of stem cell transformation
- GMP aspects in the field of stem cell transplantation
- Safety of pluripotent stem cells or embryonic stem cell transplantation
- Safety of adult stem cell transplantation
- In vitro stem cell expansion for clinical transplantation
- Manipulated stem cells (gene therapy)
Important Dates
Manuscript Due
First Round of Reviews
Publication Date

September 15, 2016
December 15, 2016
March 15, 2017

Lead Guest Editor
Lam Hoang Dang, Memorial Sloan Kettering Cancer Center (MSKCC), New York, United
States


Document preview SSCT (revised).pdf - page 1/1


Related documents


ssct revised
agcts asscr 2017 scientific program final
2016010408 10 48reena nair cv 2016
riches cv march 2016
ctc microfluidic chip amir shahein loic chaubet
v15n4s57revisiting

Link to this page


Permanent link

Use the permanent link to the download page to share your document on Facebook, Twitter, LinkedIn, or directly with a contact by e-Mail, Messenger, Whatsapp, Line..

Short link

Use the short link to share your document on Twitter or by text message (SMS)

HTML Code

Copy the following HTML code to share your document on a Website or Blog

QR Code

QR Code link to PDF file SSCT (revised).pdf